logo
logo
Sign in
Sasha Sharma
We live in a technological world, and its complexity continues to throw up challenges that require answers.
Followers 40 Following 71
Sasha Sharma 2021-11-16
img
Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – PagesDownload PDF Brochure: https://www. Based on service and product, the drug screening market is segmented into services and products. Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
collect
0
Sasha Sharma 2021-11-10
img

Increasing public-private funding for 3D printing activities, high incidence of dental and orthopedic diseases, easy development of customized medical products using 3D printing, growing applications of 3D printing in the healthcare industry, availability of advanced 3D printing materials for dental and medical applications, and the increasing demand for 3D-printed products in the cosmetics and pharmaceutical industries, are the key factors supporting the growth of the market.According to the new market research report “3D Printing Medical Devices Market by Component (3D Printer, 3D Bioprinter, Material, Software, Service), Technology (EBM, DMLS, SLS, SLA, DLP, Polyjet), Application (Surgical Guides, Prosthetics, Implants), User (Hospital, ASCs) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period.This study involved the extensive use of both primary and secondary sources.

The equipment segment is further divided into 3D printers and 3D bioprinters.

The increase in the number of training activities focusing on the developing expertise of healthcare professionals on 3D printing technology is a key factor encouraging the growth of this segment during the forecast period.Based on application, the custom prosthetics and implants segment is expected to account for the largest share of the 3D printing Medical Devices market in 2020Based on application, the market has been segmented into surgical guides, surgical instruments, standard prosthetics and implants, custom prosthetics and implants, tissue-engineered products, hearing aids, wearable medical devices/implantable medical devices, and other medical devices.

The major share of the segment is attributed to the growing number of orthopedic and CMF procedures.The external power supply segment is expected to register the highest growth rate during the forecast periodBased on technology, the 3D Printing Medical Devices market has been segmented into electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and other technologies.

This trend will have a positive impact on the Medical Devices market.Stratasys Ltd. (US & Israel), 3D Systems Corporation (US), GE Additive (US), Materialise NV (Belgium), Renishaw plc (UK), SLM Solutions Group AG (Germany), Desktop Metal, Inc. (US), Prodways Group (France), Carbon, Inc. (US), CELLINK (Sweden), Organovo Holdings, Inc. (US), EOS (Electro Optical Systems) GmbH (Germany), Biomedical Modeling, Inc. (US), Formlabs, Inc. (US), 3T Additive Manufacturing Ltd. (UK), DENTSPLY Sirona, Inc. (US), DWS Systems SRL (Italy), Roland DG (Japan), HP, Inc. (US), and regenHU (Switzerland) among others are some of the major players operating in the global 3D Printing Medical Devices market.Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Dental 3D Printing Market by Product (Material (Plastic, Metal), Equipment (3D Printer, 3D Scanner), Service), Technology (Stereolithography, FDM, SLS, Polyjet), Application (Prosthodontics, Implantology, Orthodontic), End-User – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/dental-3d-printing-market-258228239.html3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/3d-bioprinting-market-170201787.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

collect
0
Sasha Sharma 2021-11-09
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Women’s Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the global Women’s Health Diagnostics Market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.Browse in-depth TOC on “Women’s Health Diagnostics Market”245 – Tables35 – Figures246 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this markets growth to a certain extent.Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.The prenatal genetic screening & carrier testing segment is expected to grow at the highest CAGR during the forecast periodBased on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

The large share of this segment can be attributed to a greater proportion of patients (women) visiting hospitals to diagnose/treat health issues.

collect
0
Sasha Sharma 2021-11-08
img

According to the new market research report “Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region – Global Forecasts to 2026″, published by MarketsandMarkets™, the market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%.Browse in-depth TOC on “Anatomic Pathology Market”491 – Tables45 – Figures343 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.

In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years.Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market in 2020.Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments.

The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145By Application, disease diagnostics accounted for the largest market share in 2020Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research.

The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.By End User, Hospital laboratories accounted for the largest market share in 2020Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users.

The large share of this segment can be attributed to the increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.North America dominates the anatomic pathology marketThe global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).

Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals)- Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics-market-186559121.htmlImmunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

collect
0
Sasha Sharma 2021-11-15
img
In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market. Browse in-depth TOC on “Biologics Safety Testing Market”142 – Tables42 – Figures185 – PagesDownload PDF Brochure: https://www. The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020. id=34624144The Asia Pacific region is the fastest growing region of the Biologics safety testing market in 2020. Prominent players in the biologics safety testing market are Charles River Laboratories, Inc.
collect
0
Sasha Sharma 2021-11-10
img

The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to a new market research report “Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) – Global Forecast to 2021″, published by MarketsandMarkets, The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.

However, a dearth of skilled professionals is restraining the growth of this market.Browse in-depth TOC on “Non-Invasive Prenatal Testing (NIPT) Market”110  tables48 figures150 pagesDownload PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=145607690The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies).

Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.The Non-Invasive Prenatal Testing Market is segmented based on product, method, application, end user, and region.

Factors such as high risk of chromosomal disorders with increasing maternal age and rising government investments are driving the growth of the NIPT market in this region.

collect
0
Sasha Sharma 2021-11-08
img

Growth in the esoteric testing market is primarily driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the esoteric testing market.What the Market Looks Like?

[244 Pages Report] The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.

Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market.

In contrast, inadequate reimbursements of the esoteric tests may restrict market growth to a certain extent.

The esoteric testing market is segmented based on type, technology, end user and region.COVID-19 impact on the esoteric testing marketThe growth of the esoteric testing market has declined due to the sudden outbreak of the COVID-19 pandemic.

In the first quarter of 2020, companies faced certain operational and logistic challenges due to the imposition of lockdowns.

collect
0
Sasha Sharma 2021-11-03
img

The study involved four major activities in estimating the current size of the laboratory filtration market.

The next step was to validate these findings, assumptions, and sizes with industry experts across the value chain through primary research.

Both the top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F), Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Laboratory Filtration Market is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3%.Browse in-depth TOC on “Laboratory Filtration Market“169 – Tables53 – Figures221 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082Growth in this market is majorly driven by the increasing demand for laboratory filters in pharmaceutical & biotechnology companies and growing R investments in the pharmaceutical and biopharmaceutical industries.

The microfiltration segment accounted for the largest share of the market, by technique, in 2018Based on technique, the Laboratory Filtration Market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration.

Rising R activities in the pharma industry and wide applications in the food & beverage industry are the key factors boosting segmental growth.

The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.The prominent players in the global Laboratory Filtration Market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Pharmaceutical Membrane Filtration Market by Product (Filter, Systems), Technique (Microfiltration, Ultrafiltration), Material (PES, PVDF, PTFE, PCTE), Application (Final Product (Sterile), Raw Material (Bioburden), Cell Separation, Air) – Global Forecast to 2024Hollow Fiber Filtration Market by Technique (Microfiltration, Ultrafiltration), Material (Polymer, Ceramic), Application (Harvest & Clarification, Concentration, Perfusion), End User (Pharmaceutical Manufacturer, CRO, CMO) – Global Forecast to 2023About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

collect
0
Sasha Sharma 2021-11-11
img

This study involved four major activities in estimating the size of the healthcare BPO market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research.According to the new market research report “Healthcare BPO Market by Outsourcing Models, Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Life Science (R, Manufacturing, Sales & Marketing (Analytics, Research)), & Region (Source, Destination) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 468.5 billion by 2026 from an estimated USD 296.4 billion in 2021, at a CAGR of 9.6%.Healthcare business process outsourcing allows healthcare facilities to contract their non-core activities to an external party and focus on their core competencies.

Growth of this market is attributed to the growing outsourcing in the pharma and biopharma industries, need to curtail the escalating healthcare costs, rising demand for niche services (including care management and fraud detection services), and the need for structured processes and documentation in the healthcare industry.Browse in-depth TOC on “Healthcare BPO Market”334 – Tables43 – Figures309 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472Growth in this market is primarily driven by the need to reduce rising healthcare costs and the implementation of the Patient Protection and Affordable Care Act (PPACA) are compelling payers and providers to outsource their business processes to low-cost countries in order to reduce their operational costs.The major source geographies that primarily outsource most of their non-core activities to third parties include North America, Europe, and Rest of the World.The COVID-19 pandemic has had a significant impact on the world’s population and economy.

As a result of the pandemic, healthcare facilities are facing immense pressure to create a well-coordinated environment where all clinical functions are connected internally and where the organization operates in coordination with other healthcare units.

This is compelling healthcare organizations to outsource their non-core functions, including revenue cycle management, claims management, and patient engagement, among other functions, to third parties and focus on their core competencies for better patient outcomes.Revenue cycle management services to register the highest growth in the Healthcare BPO marketBased on type, the market is segmented into revenue cycle management, patient enrollment, and patient care.

This can be attributed to the constantly changing regulations on testing and clinical trials, the need to reduce overall operational costs and increasing focus on accelerating the drug development process while maintaining high levels of safety and control.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=472North American healthcare BPO market to register the largest and highest growth from 2021 to 2026North America dominated the market, with a share of 48.6% in 2020, and is expected to register the highest CAGR of 10.6% during the forecast period.

collect
0
Sasha Sharma 2021-11-09
img

This study involved four major activities in estimating the current size of the biomaterials market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) – Global Forecast to 2025″, published by MarketsandMarkets™, the global Biomaterials Market is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.Biomaterials market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.

In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.Browse in-depth TOC on “Biomaterials Market”333 – Tables47 – Figures298 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393The Growth in this market is primarily attributed to increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidences of cardiovascular diseases, and rising awareness and research on regenerative medicine.The metallic biomaterials segment accounted for the largest share of the type segment in the market in 2019.On the basis type of materials, the biomaterials market is broadly segmented into Metallic, Polymeric, Ceramic, and Natural biomaterials.

This can primarily be attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications.The cardiovascular application segment accounted for the largest share of the application segment in the market in 2019.Based on application, the biomaterials market is categorized into seven segments— cardiovascular, orthopedic, ophthalmology, neurological/central nervous system (CNS), dental, tissue engineering, wound healing, plastic surgery, and other applications.

It is also estimated to grow at the highest CAGR in the metallic biomaterials market during the forecast period, this is mainly due to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.Some of the prominent players in the biomaterials market are BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Medical Ceramics Market by Material (Zirconia, Alumina, Hydroxyapatite, Glass, Bioresorbable, Bioinert, Bioactive, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Diagnostic, Surgical Implants, Dermal Fillers) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/medical-ceramic-market-237425129.htmlDental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital)- Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

collect
0
Sasha Sharma 2021-11-08
img

The Growth in this DTx market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.

On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.According to the new market research report “Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global Forecasts to 2026″, published by MarketsandMarkets™, the Global DTx Market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period.Browse in-depth TOC on “Digital Therapeutics (DTx) Market”157 – Tables27 – Figures204 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The study involved four major activities in estimating the current size of the global digital therapeutics market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the total market size.Treatment/care-related applications form the largest segment of the market, by application.Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.

The large share of this segment is attributed to the growing incidences of chronic diseases, the rising economic burden of their treatment, and investments in digital therapeutics to encourage the development of cost-effective and scalable treatment platforms for these conditions.The B2B segment is the largest and fastest-growing segment of the market during the forecast period.Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

Factors such as the influx of new start-ups, increasing investments in digital therapeutics, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region.Prominent players in the digital therapeutics market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Proteus Digital Health (US), Propeller Health (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), CogniFit (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), and Ginger (US).Browse Adjacent Markets: Healthcare IT Market Research Reports & ConsultingBrowse Related Reports:Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User (Hospitals & Self/home healthcare) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/digital-diabetes-management-market-144725893.htmlBehavioural/Mental Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership), Functionality (Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial), End User (Hospitals, Clinics) – Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/behavioral-health-software-market-45953340.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

collect
0
Sasha Sharma 2021-11-03
img

However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.According to the new market research report “North American Nuclear Medicine Market by Type (Diagnostic (SPECT – Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) – Forecasts to 2024″, published by MarketsandMarkets™, the North American Radiopharmaceuticals Market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, at a CAGR of 4.1%.The study involved four major activities in estimating the current size for the North American nuclear medicine market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

F-18 is a major isotope used in oncological applications such as breast cancer and bone metastasis.By procedural volume assessment, the Tc-99m procedures segment is expected to account for the largest share of the SPECT procedures market in 2019Based on procedural volume assessment, the market is segmented into SPECT, PET, and therapeutic procedures.

The growth of this market can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the countryThe prominent players in the global North American Nuclear Medicine Market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Nuclear Medicine/ Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) – Global Forecasts to 2023Radiation Detection, Monitoring, & Safety Market by Product (Detection & Monitoring, Safety), Composition (Gas-filled detectors, Scintillator, Solid-state detector), Application (Healthcare, Homeland Security& Defence, Industrial) – Global Forecast to 2022About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

collect
0
Sasha Sharma 2021-11-10
img

The study involved four major activities to estimate the current size of the radiation dose management market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™, the Radiation Dose Management Market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.Growth of the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.Browse in-depth TOC on “Radiation Dose Management Market“300 – Tables33 – Figures  226 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344The growth in this market is attributed to the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.Radiation dose management solutions accounted for the larger share of the Radiation Dose Management Market in 2019On the basis of product & service, the market is segmented into radiation dose management solutions and radiation dose management services.

The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, and the increasing awareness of the harmful effects of radiation exposure are some of the major factors responsible for the high demand for radiation dose management solutions in hospitals.North America dominates the global Radiation Dose Management MarketThe market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.

The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety.The major players in the Radiation Dose Management Market are Bayer AG (Germany), GE Healthcare (US), PACSHealth, LLC (US), and Sectra Medical Systems (Sweden).

collect
0
Sasha Sharma 2021-11-09
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Inspection Machines Market by Product (Vision Inspection, Checkweigher, Metal Detector, Software), Type (Manual, Automatic), Packaging Type (Vials, Syringes, Blisters), End User (Pharmaceutical, Medical Device), COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the Inspection machine market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.Browse in-depth TOC on “Inspection Machines Market”134 – Tables46 – Figures231 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP).

Also, the complexities of introducing inspection machines in a production line may hamper the market’s growth to a certain extent.Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

Growth in this segment is driven mostly by the increasing demand for faster inspection of products in the manufacturing process and minimal human inspection leads to the growth of adopting digital solutions for better imaging and accuracy.

The real-time defect tracking capability of these systems makes it a choice to avoid re-inspection, and are thus being adopted across various industries.Syringes segment is expected to grow at the highest rate during the forecast periodBased on application, the inspection machines market is segmented into ampoules & vials, syringes, blister packaging, bottles, and other packaging types.

Factors such as the increasing number of regulatory mandates in the healthcare industry to maintain compliance with good manufacturing practices (GMP); the growing number of pharmaceutical & biotechnology manufacturers; significant economic development in emerging markets such as China and India; tremendous growth in the pharmaceutical, food processing & packaging, and medical device industries; and favorable government initiatives to promote the inspection of products in the pharmaceutical & biopharmaceutical industries are expected to drive the growth of this market during the forecast period.The prominent players in this inspection machines market are Robert Bosch GmbH (Germany), Körber AG (Germany), METTLER-TOLEDO International Inc. (US), ACG Group (India), Cognex Corporation (US), OMRON Corporation (Japan), Teledyne Technologies Incorporated (US), Brevetti CEA SpA (Italy).Browse Adjacent Markets: Pharmaceuticals Market Research Reports & ConsultingBrowse Related Reports:Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.htmlFluoroscopy Equipment Marketby Product (Fixed C-Arms, Fluoroscopy Systems (Remote Controlled, Patient Side), Mobile C-arms), and Application (Diagnostic (Cardio, Gastroenterology, Nephrology), Surgical (Ortho, Neuro, Cardio) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/fluoroscopy-equipment-market-23056341.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

collect
0
Sasha Sharma 2021-11-08
img

The Growth in this HIE Market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperability.

However, data privacy concerns, need for significant investments in infrastructure development and high cost of deployment, lack of true interoperable solutions are expected to hinder the market growth.According to the new market research report “Health Information Exchange (HIE) Market by Set Up Type (Public, Private), Implementation Model (Federated, Hybrid), Type (Pull, Push), Application (Web Portal, Secure Messaging), Solution (Portal, Platform Centric), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the global Health Information Exchange Market is expected to reach 2.0 billion by 2025 from an estimated USD 1.1 billion in 2020 at a CAGR of 12.2% during the forecast period.This study involved four major activities in estimating the size of the health information exchange market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research.

The private HIE segment is expected to account for the largest share of the market in 2020.

The large share and high growth can be attributed to the various advantages it offers as compared to public HIEs, such as additional functionalities and strong technical support.The hybrid model is expected to grow at the highest rate during the forecast periodBased on the implementation model, the health information exchange market is segmented into centralized/consolidated model, federated/decentralized, hybrid models.

The large share and high growth can be attributed to the various advantages it offers as such as controlled flow of data and support to diverse communities, cost-effective database solution and is often the only choice for cost-constrained organizations.The directed exchange segment to account for the largest share during the forecast periodBased on the type, the health information exchange market is segmented into directed (push HIE), query-based (pull-HIE), consumer-mediated exchange solutions.

collect
0
Sasha Sharma 2021-11-03
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) – Global Forecast to 2026″, published by MarketsandMarkets™, the Laboratory Freezers Market is projected to reach USD 5.7 billion by 2026 from USD 4.7 billion in 2022, at a CAGR of 4.9%.The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 due to the utility of these products for appropriate temperature-controlled storage of COVID-19 vaccines.

The growing use of refurbished laboratory freezers and refrigerators could restrain the growth of this market.Browse in-depth TOC on “Laboratory Freezers Market”274 – Tables52 – Figures291 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196600540The Growth in the market is driven by the increasing demand for blood and blood components for transfusion and for support in cancer therapy.The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 due to the utility of these products for appropriate temperature-controlled storage of COVID-19 vaccines.

The large share of this segment can be attributed to their utility in pharmaceutical and biotechnology companies and academic and research institutes to support vaccine development and in medical laboratories and hospitals for storing test samples.The laboratory refrigerators segment holds the highest share in the refrigerators segmentBased on type, the laboratory freezers market is segmented into blood bank refrigerators, chromatography refrigerators, explosion-proof refrigerators, flammable material refrigerators, laboratory refrigerators, and pharmacy refrigerators.

Latin America is one of the fastest-growing markets for laboratory freezers owing to growing investments from global pharmaceutical manufacturers in Latin America and the availability of government funding for R activities as well as efforts to modernize the existing healthcare system.Prominent players in the laboratory freezers market include Eppendorf AG (Germany), Haier Biomedical (China), Thermo Fisher Scientific, Inc. (US), Helmer Scientific (US), PHC Holdings Corporation (Japan), Liebherr (Switzerland), Middleby Corporation (Follett Products, LLC), Felix Storch, Inc. (US), BioLife Solutions, Inc. (Stirling Ultracold) (US), Blue Star Limited (India), B Medical Systems (Luxembourg), Philipp Kirsch GmbH (Germany), Avantor, Inc. (US), Standex International Corporation (US), Vestfrost Solutions A/S (Denmark), Changhong Meiling Co. Ltd. (China), EVERmed S.R.L.

(Italy), ARCTIKO A/S (Denmark), Glen Dimplex Medical Appliances (LEC Medical) (Ireland), So-Low Environmental Equipment Co. Ltd. (US), KW Apparecchi Scientifici SRL (Italy), Jeio Tech (Republic of Korea), Refrigerated Solutions Group (US), Stericox India Private Limited (India), Thalheimer Kühlung (Germany), and Antylia Scientific (US).Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.htmlLaboratory Equipment Services Market by Type (Repair & Maintenance, Calibration, Validation), Contract (Standard, Custom), Equipment (Analytical, Equipment, General, Support), Service Provider (OEM), and End User (Pharmaceutical) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/laboratory-equipment-service-market-171213101.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

collect
0
Sasha Sharma 2021-11-16
img
Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – PagesDownload PDF Brochure: https://www. Based on service and product, the drug screening market is segmented into services and products. Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Sasha Sharma 2021-11-11
img

This study involved four major activities in estimating the size of the healthcare BPO market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research.According to the new market research report “Healthcare BPO Market by Outsourcing Models, Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Life Science (R, Manufacturing, Sales & Marketing (Analytics, Research)), & Region (Source, Destination) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 468.5 billion by 2026 from an estimated USD 296.4 billion in 2021, at a CAGR of 9.6%.Healthcare business process outsourcing allows healthcare facilities to contract their non-core activities to an external party and focus on their core competencies.

Growth of this market is attributed to the growing outsourcing in the pharma and biopharma industries, need to curtail the escalating healthcare costs, rising demand for niche services (including care management and fraud detection services), and the need for structured processes and documentation in the healthcare industry.Browse in-depth TOC on “Healthcare BPO Market”334 – Tables43 – Figures309 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472Growth in this market is primarily driven by the need to reduce rising healthcare costs and the implementation of the Patient Protection and Affordable Care Act (PPACA) are compelling payers and providers to outsource their business processes to low-cost countries in order to reduce their operational costs.The major source geographies that primarily outsource most of their non-core activities to third parties include North America, Europe, and Rest of the World.The COVID-19 pandemic has had a significant impact on the world’s population and economy.

As a result of the pandemic, healthcare facilities are facing immense pressure to create a well-coordinated environment where all clinical functions are connected internally and where the organization operates in coordination with other healthcare units.

This is compelling healthcare organizations to outsource their non-core functions, including revenue cycle management, claims management, and patient engagement, among other functions, to third parties and focus on their core competencies for better patient outcomes.Revenue cycle management services to register the highest growth in the Healthcare BPO marketBased on type, the market is segmented into revenue cycle management, patient enrollment, and patient care.

This can be attributed to the constantly changing regulations on testing and clinical trials, the need to reduce overall operational costs and increasing focus on accelerating the drug development process while maintaining high levels of safety and control.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=472North American healthcare BPO market to register the largest and highest growth from 2021 to 2026North America dominated the market, with a share of 48.6% in 2020, and is expected to register the highest CAGR of 10.6% during the forecast period.

Sasha Sharma 2021-11-10
img

Increasing public-private funding for 3D printing activities, high incidence of dental and orthopedic diseases, easy development of customized medical products using 3D printing, growing applications of 3D printing in the healthcare industry, availability of advanced 3D printing materials for dental and medical applications, and the increasing demand for 3D-printed products in the cosmetics and pharmaceutical industries, are the key factors supporting the growth of the market.According to the new market research report “3D Printing Medical Devices Market by Component (3D Printer, 3D Bioprinter, Material, Software, Service), Technology (EBM, DMLS, SLS, SLA, DLP, Polyjet), Application (Surgical Guides, Prosthetics, Implants), User (Hospital, ASCs) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period.This study involved the extensive use of both primary and secondary sources.

The equipment segment is further divided into 3D printers and 3D bioprinters.

The increase in the number of training activities focusing on the developing expertise of healthcare professionals on 3D printing technology is a key factor encouraging the growth of this segment during the forecast period.Based on application, the custom prosthetics and implants segment is expected to account for the largest share of the 3D printing Medical Devices market in 2020Based on application, the market has been segmented into surgical guides, surgical instruments, standard prosthetics and implants, custom prosthetics and implants, tissue-engineered products, hearing aids, wearable medical devices/implantable medical devices, and other medical devices.

The major share of the segment is attributed to the growing number of orthopedic and CMF procedures.The external power supply segment is expected to register the highest growth rate during the forecast periodBased on technology, the 3D Printing Medical Devices market has been segmented into electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and other technologies.

This trend will have a positive impact on the Medical Devices market.Stratasys Ltd. (US & Israel), 3D Systems Corporation (US), GE Additive (US), Materialise NV (Belgium), Renishaw plc (UK), SLM Solutions Group AG (Germany), Desktop Metal, Inc. (US), Prodways Group (France), Carbon, Inc. (US), CELLINK (Sweden), Organovo Holdings, Inc. (US), EOS (Electro Optical Systems) GmbH (Germany), Biomedical Modeling, Inc. (US), Formlabs, Inc. (US), 3T Additive Manufacturing Ltd. (UK), DENTSPLY Sirona, Inc. (US), DWS Systems SRL (Italy), Roland DG (Japan), HP, Inc. (US), and regenHU (Switzerland) among others are some of the major players operating in the global 3D Printing Medical Devices market.Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Dental 3D Printing Market by Product (Material (Plastic, Metal), Equipment (3D Printer, 3D Scanner), Service), Technology (Stereolithography, FDM, SLS, Polyjet), Application (Prosthodontics, Implantology, Orthodontic), End-User – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/dental-3d-printing-market-258228239.html3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/3d-bioprinting-market-170201787.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

Sasha Sharma 2021-11-09
img

This study involved four major activities in estimating the current size of the biomaterials market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) – Global Forecast to 2025″, published by MarketsandMarkets™, the global Biomaterials Market is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.Biomaterials market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.

In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.Browse in-depth TOC on “Biomaterials Market”333 – Tables47 – Figures298 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393The Growth in this market is primarily attributed to increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidences of cardiovascular diseases, and rising awareness and research on regenerative medicine.The metallic biomaterials segment accounted for the largest share of the type segment in the market in 2019.On the basis type of materials, the biomaterials market is broadly segmented into Metallic, Polymeric, Ceramic, and Natural biomaterials.

This can primarily be attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications.The cardiovascular application segment accounted for the largest share of the application segment in the market in 2019.Based on application, the biomaterials market is categorized into seven segments— cardiovascular, orthopedic, ophthalmology, neurological/central nervous system (CNS), dental, tissue engineering, wound healing, plastic surgery, and other applications.

It is also estimated to grow at the highest CAGR in the metallic biomaterials market during the forecast period, this is mainly due to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.Some of the prominent players in the biomaterials market are BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Medical Ceramics Market by Material (Zirconia, Alumina, Hydroxyapatite, Glass, Bioresorbable, Bioinert, Bioactive, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Diagnostic, Surgical Implants, Dermal Fillers) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/medical-ceramic-market-237425129.htmlDental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital)- Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Sasha Sharma 2021-11-09
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Women’s Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the global Women’s Health Diagnostics Market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.Browse in-depth TOC on “Women’s Health Diagnostics Market”245 – Tables35 – Figures246 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this markets growth to a certain extent.Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.The prenatal genetic screening & carrier testing segment is expected to grow at the highest CAGR during the forecast periodBased on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

The large share of this segment can be attributed to a greater proportion of patients (women) visiting hospitals to diagnose/treat health issues.

Sasha Sharma 2021-11-08
img

The Growth in this DTx market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.

On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.According to the new market research report “Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global Forecasts to 2026″, published by MarketsandMarkets™, the Global DTx Market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period.Browse in-depth TOC on “Digital Therapeutics (DTx) Market”157 – Tables27 – Figures204 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724The study involved four major activities in estimating the current size of the global digital therapeutics market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the total market size.Treatment/care-related applications form the largest segment of the market, by application.Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.

The large share of this segment is attributed to the growing incidences of chronic diseases, the rising economic burden of their treatment, and investments in digital therapeutics to encourage the development of cost-effective and scalable treatment platforms for these conditions.The B2B segment is the largest and fastest-growing segment of the market during the forecast period.Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).

Factors such as the influx of new start-ups, increasing investments in digital therapeutics, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region.Prominent players in the digital therapeutics market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Proteus Digital Health (US), Propeller Health (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), CogniFit (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), and Ginger (US).Browse Adjacent Markets: Healthcare IT Market Research Reports & ConsultingBrowse Related Reports:Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User (Hospitals & Self/home healthcare) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/digital-diabetes-management-market-144725893.htmlBehavioural/Mental Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership), Functionality (Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial), End User (Hospitals, Clinics) – Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/behavioral-health-software-market-45953340.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Sasha Sharma 2021-11-08
img

According to the new market research report “Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region – Global Forecasts to 2026″, published by MarketsandMarkets™, the market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%.Browse in-depth TOC on “Anatomic Pathology Market”491 – Tables45 – Figures343 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.

In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years.Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market in 2020.Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments.

The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145By Application, disease diagnostics accounted for the largest market share in 2020Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research.

The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.By End User, Hospital laboratories accounted for the largest market share in 2020Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users.

The large share of this segment can be attributed to the increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.North America dominates the anatomic pathology marketThe global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).

Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals)- Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics-market-186559121.htmlImmunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Sasha Sharma 2021-11-03
img

However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.According to the new market research report “North American Nuclear Medicine Market by Type (Diagnostic (SPECT – Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) – Forecasts to 2024″, published by MarketsandMarkets™, the North American Radiopharmaceuticals Market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, at a CAGR of 4.1%.The study involved four major activities in estimating the current size for the North American nuclear medicine market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

F-18 is a major isotope used in oncological applications such as breast cancer and bone metastasis.By procedural volume assessment, the Tc-99m procedures segment is expected to account for the largest share of the SPECT procedures market in 2019Based on procedural volume assessment, the market is segmented into SPECT, PET, and therapeutic procedures.

The growth of this market can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the countryThe prominent players in the global North American Nuclear Medicine Market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Nuclear Medicine/ Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) – Global Forecasts to 2023Radiation Detection, Monitoring, & Safety Market by Product (Detection & Monitoring, Safety), Composition (Gas-filled detectors, Scintillator, Solid-state detector), Application (Healthcare, Homeland Security& Defence, Industrial) – Global Forecast to 2022About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

Sasha Sharma 2021-11-15
img
In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market. Browse in-depth TOC on “Biologics Safety Testing Market”142 – Tables42 – Figures185 – PagesDownload PDF Brochure: https://www. The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020. id=34624144The Asia Pacific region is the fastest growing region of the Biologics safety testing market in 2020. Prominent players in the biologics safety testing market are Charles River Laboratories, Inc.
Sasha Sharma 2021-11-10
img

The study involved four major activities to estimate the current size of the radiation dose management market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™, the Radiation Dose Management Market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.Growth of the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.Browse in-depth TOC on “Radiation Dose Management Market“300 – Tables33 – Figures  226 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344The growth in this market is attributed to the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.Radiation dose management solutions accounted for the larger share of the Radiation Dose Management Market in 2019On the basis of product & service, the market is segmented into radiation dose management solutions and radiation dose management services.

The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, and the increasing awareness of the harmful effects of radiation exposure are some of the major factors responsible for the high demand for radiation dose management solutions in hospitals.North America dominates the global Radiation Dose Management MarketThe market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.

The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety.The major players in the Radiation Dose Management Market are Bayer AG (Germany), GE Healthcare (US), PACSHealth, LLC (US), and Sectra Medical Systems (Sweden).

Sasha Sharma 2021-11-10
img

The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.According to a new market research report “Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) – Global Forecast to 2021″, published by MarketsandMarkets, The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.

However, a dearth of skilled professionals is restraining the growth of this market.Browse in-depth TOC on “Non-Invasive Prenatal Testing (NIPT) Market”110  tables48 figures150 pagesDownload PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=145607690The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies).

Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.The Non-Invasive Prenatal Testing Market is segmented based on product, method, application, end user, and region.

Factors such as high risk of chromosomal disorders with increasing maternal age and rising government investments are driving the growth of the NIPT market in this region.

Sasha Sharma 2021-11-09
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Inspection Machines Market by Product (Vision Inspection, Checkweigher, Metal Detector, Software), Type (Manual, Automatic), Packaging Type (Vials, Syringes, Blisters), End User (Pharmaceutical, Medical Device), COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the Inspection machine market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.Browse in-depth TOC on “Inspection Machines Market”134 – Tables46 – Figures231 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP).

Also, the complexities of introducing inspection machines in a production line may hamper the market’s growth to a certain extent.Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

Growth in this segment is driven mostly by the increasing demand for faster inspection of products in the manufacturing process and minimal human inspection leads to the growth of adopting digital solutions for better imaging and accuracy.

The real-time defect tracking capability of these systems makes it a choice to avoid re-inspection, and are thus being adopted across various industries.Syringes segment is expected to grow at the highest rate during the forecast periodBased on application, the inspection machines market is segmented into ampoules & vials, syringes, blister packaging, bottles, and other packaging types.

Factors such as the increasing number of regulatory mandates in the healthcare industry to maintain compliance with good manufacturing practices (GMP); the growing number of pharmaceutical & biotechnology manufacturers; significant economic development in emerging markets such as China and India; tremendous growth in the pharmaceutical, food processing & packaging, and medical device industries; and favorable government initiatives to promote the inspection of products in the pharmaceutical & biopharmaceutical industries are expected to drive the growth of this market during the forecast period.The prominent players in this inspection machines market are Robert Bosch GmbH (Germany), Körber AG (Germany), METTLER-TOLEDO International Inc. (US), ACG Group (India), Cognex Corporation (US), OMRON Corporation (Japan), Teledyne Technologies Incorporated (US), Brevetti CEA SpA (Italy).Browse Adjacent Markets: Pharmaceuticals Market Research Reports & ConsultingBrowse Related Reports:Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.htmlFluoroscopy Equipment Marketby Product (Fixed C-Arms, Fluoroscopy Systems (Remote Controlled, Patient Side), Mobile C-arms), and Application (Diagnostic (Cardio, Gastroenterology, Nephrology), Surgical (Ortho, Neuro, Cardio) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/fluoroscopy-equipment-market-23056341.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.

Sasha Sharma 2021-11-08
img

Growth in the esoteric testing market is primarily driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the esoteric testing market.What the Market Looks Like?

[244 Pages Report] The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.

Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market.

In contrast, inadequate reimbursements of the esoteric tests may restrict market growth to a certain extent.

The esoteric testing market is segmented based on type, technology, end user and region.COVID-19 impact on the esoteric testing marketThe growth of the esoteric testing market has declined due to the sudden outbreak of the COVID-19 pandemic.

In the first quarter of 2020, companies faced certain operational and logistic challenges due to the imposition of lockdowns.

Sasha Sharma 2021-11-08
img

The Growth in this HIE Market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperability.

However, data privacy concerns, need for significant investments in infrastructure development and high cost of deployment, lack of true interoperable solutions are expected to hinder the market growth.According to the new market research report “Health Information Exchange (HIE) Market by Set Up Type (Public, Private), Implementation Model (Federated, Hybrid), Type (Pull, Push), Application (Web Portal, Secure Messaging), Solution (Portal, Platform Centric), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the global Health Information Exchange Market is expected to reach 2.0 billion by 2025 from an estimated USD 1.1 billion in 2020 at a CAGR of 12.2% during the forecast period.This study involved four major activities in estimating the size of the health information exchange market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research.

The private HIE segment is expected to account for the largest share of the market in 2020.

The large share and high growth can be attributed to the various advantages it offers as compared to public HIEs, such as additional functionalities and strong technical support.The hybrid model is expected to grow at the highest rate during the forecast periodBased on the implementation model, the health information exchange market is segmented into centralized/consolidated model, federated/decentralized, hybrid models.

The large share and high growth can be attributed to the various advantages it offers as such as controlled flow of data and support to diverse communities, cost-effective database solution and is often the only choice for cost-constrained organizations.The directed exchange segment to account for the largest share during the forecast periodBased on the type, the health information exchange market is segmented into directed (push HIE), query-based (pull-HIE), consumer-mediated exchange solutions.

Sasha Sharma 2021-11-03
img

The study involved four major activities in estimating the current size of the laboratory filtration market.

The next step was to validate these findings, assumptions, and sizes with industry experts across the value chain through primary research.

Both the top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F), Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Laboratory Filtration Market is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3%.Browse in-depth TOC on “Laboratory Filtration Market“169 – Tables53 – Figures221 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082Growth in this market is majorly driven by the increasing demand for laboratory filters in pharmaceutical & biotechnology companies and growing R investments in the pharmaceutical and biopharmaceutical industries.

The microfiltration segment accounted for the largest share of the market, by technique, in 2018Based on technique, the Laboratory Filtration Market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration.

Rising R activities in the pharma industry and wide applications in the food & beverage industry are the key factors boosting segmental growth.

The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.The prominent players in the global Laboratory Filtration Market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Pharmaceutical Membrane Filtration Market by Product (Filter, Systems), Technique (Microfiltration, Ultrafiltration), Material (PES, PVDF, PTFE, PCTE), Application (Final Product (Sterile), Raw Material (Bioburden), Cell Separation, Air) – Global Forecast to 2024Hollow Fiber Filtration Market by Technique (Microfiltration, Ultrafiltration), Material (Polymer, Ceramic), Application (Harvest & Clarification, Concentration, Perfusion), End User (Pharmaceutical Manufacturer, CRO, CMO) – Global Forecast to 2023About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Sasha Sharma 2021-11-03
img

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.According to the new market research report “Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) – Global Forecast to 2026″, published by MarketsandMarkets™, the Laboratory Freezers Market is projected to reach USD 5.7 billion by 2026 from USD 4.7 billion in 2022, at a CAGR of 4.9%.The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 due to the utility of these products for appropriate temperature-controlled storage of COVID-19 vaccines.

The growing use of refurbished laboratory freezers and refrigerators could restrain the growth of this market.Browse in-depth TOC on “Laboratory Freezers Market”274 – Tables52 – Figures291 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196600540The Growth in the market is driven by the increasing demand for blood and blood components for transfusion and for support in cancer therapy.The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 due to the utility of these products for appropriate temperature-controlled storage of COVID-19 vaccines.

The large share of this segment can be attributed to their utility in pharmaceutical and biotechnology companies and academic and research institutes to support vaccine development and in medical laboratories and hospitals for storing test samples.The laboratory refrigerators segment holds the highest share in the refrigerators segmentBased on type, the laboratory freezers market is segmented into blood bank refrigerators, chromatography refrigerators, explosion-proof refrigerators, flammable material refrigerators, laboratory refrigerators, and pharmacy refrigerators.

Latin America is one of the fastest-growing markets for laboratory freezers owing to growing investments from global pharmaceutical manufacturers in Latin America and the availability of government funding for R activities as well as efforts to modernize the existing healthcare system.Prominent players in the laboratory freezers market include Eppendorf AG (Germany), Haier Biomedical (China), Thermo Fisher Scientific, Inc. (US), Helmer Scientific (US), PHC Holdings Corporation (Japan), Liebherr (Switzerland), Middleby Corporation (Follett Products, LLC), Felix Storch, Inc. (US), BioLife Solutions, Inc. (Stirling Ultracold) (US), Blue Star Limited (India), B Medical Systems (Luxembourg), Philipp Kirsch GmbH (Germany), Avantor, Inc. (US), Standex International Corporation (US), Vestfrost Solutions A/S (Denmark), Changhong Meiling Co. Ltd. (China), EVERmed S.R.L.

(Italy), ARCTIKO A/S (Denmark), Glen Dimplex Medical Appliances (LEC Medical) (Ireland), So-Low Environmental Equipment Co. Ltd. (US), KW Apparecchi Scientifici SRL (Italy), Jeio Tech (Republic of Korea), Refrigerated Solutions Group (US), Stericox India Private Limited (India), Thalheimer Kühlung (Germany), and Antylia Scientific (US).Browse Adjacent Markets: Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.htmlLaboratory Equipment Services Market by Type (Repair & Maintenance, Calibration, Validation), Contract (Standard, Custom), Equipment (Analytical, Equipment, General, Support), Service Provider (OEM), and End User (Pharmaceutical) – Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/laboratory-equipment-service-market-171213101.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.